LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 232

Search options

  1. Article: Interview mit Prof. Dr. Baptist Gallwitz: NEUE WAFFEN GEGEN DIABETES TYP 2 - INKRETINBASIERTE PRÄPARATE. Was können intelligente Therapiekonzepte bewirken?

    Gallwitz, Baptist

    MedReview

    2010  Volume 11, Issue 6, Page(s) 6

    Language German
    Document type Article
    ZDB-ID 2041837-1
    ISSN 1615-777X
    Database Current Contents Medicine

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 5407: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: Stufentherapie des Typ-2-Diabetes.

    Gallwitz, Baptist

    MMW Fortschritte der Medizin

    2023  Volume 165, Issue Suppl 3, Page(s) 61–66

    Title translation Type-2-Diabetes: choosing antidiabetic therapy depending on comorbidities.
    MeSH term(s) Humans ; Hypoglycemic Agents/adverse effects ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/epidemiology ; Sodium-Glucose Transporter 2 Inhibitors ; Comorbidity ; Glucagon-Like Peptide-1 Receptor ; Cardiovascular Diseases/epidemiology
    Chemical Substances Hypoglycemic Agents ; Sodium-Glucose Transporter 2 Inhibitors ; Glucagon-Like Peptide-1 Receptor
    Language German
    Publishing date 2023-10-19
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1478211-x
    ISSN 1613-3560 ; 1438-3276
    ISSN (online) 1613-3560
    ISSN 1438-3276
    DOI 10.1007/s15006-023-2996-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Ua VI Zs.20: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)
    Zs.MG 72: Show issues

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Book: Herz und Typ-2-Diabetes

    Gallwitz, Baptist / Lehrke, Michael

    (Refresher Dermatologie ; 2017, 1 (Dezember 2017))

    2017  

    Author's details Baptist Gallwitz, Michael Lehrke
    Series title Refresher Dermatologie ; 2017, 1 (Dezember 2017)
    Collection
    Language German
    Size 14 Seiten, Diagramme
    Publisher Thieme
    Publishing place Stuttgart
    Publishing country Germany
    Document type Book
    HBZ-ID HT019625261
    Database Catalogue ZB MED Medicine, Health

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    Zs A 7135 -2017,1- verfügbar in Königswinter Königswinter

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Book: Herz und Typ-2-Diabetes

    Gallwitz, Baptist / Lehrke, Michael

    (Refresher Diabetologie ; 2017, Nr. 1 (Dezember 2017))

    2017  

    Author's details Baptist Gallwitz, Michael Lehrke
    Series title Refresher Diabetologie ; 2017, Nr. 1 (Dezember 2017)
    Collection
    Language German
    Size 14 Seiten, Diagramme
    Publisher Thieme
    Publishing place Stuttgart
    Publishing country Germany
    Document type Book
    HBZ-ID HT019684329
    Database Catalogue ZB MED Medicine, Health

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    Zs A 6933 -2017,1- verfügbar in Königswinter Königswinter

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  5. Book: Typ-2-Diabetes

    Gallwitz, Baptist

    individualisierte Diabetestherapie - was ist im Praxisalltag zu beachten?

    (Thieme-Praxis-Report ; 5,10)

    2013  

    Author's details [Hrsg. Baptist Gallwitz ...]
    Series title Thieme-Praxis-Report ; 5,10
    Collection
    Language German
    Size 11 S. : Ill., graph. Darst.
    Publisher Thieme
    Publishing place Stuttgart u.a.
    Publishing country Germany
    Document type Book
    HBZ-ID HT017905999
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    Zs A 6809 -5,10- verfügbar in Königswinter Königswinter

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  6. Article ; Online: Gastrointestinale Hormone – zunehmende arzneitherapeutische Bedeutung bei Stoffwechselerkrankungen.

    Gallwitz, Baptist

    Innere Medizin (Heidelberg, Germany)

    2023  Volume 64, Issue 2, Page(s) 205–210

    Abstract: Gastrointestinal hormones play an important role in the endocrine communication between the intestine, the pancreas, the liver and the brain. Glucagon-like peptide‑1 receptor agonists (GLP-1RA) are established therapeutic agents in the treatment of type‑ ... ...

    Title translation Gastrointestinal hormones: their increasing pharmacotherapeutic relevance in metabolic diseases.
    Abstract Gastrointestinal hormones play an important role in the endocrine communication between the intestine, the pancreas, the liver and the brain. Glucagon-like peptide‑1 receptor agonists (GLP-1RA) are established therapeutic agents in the treatment of type‑2 diabetes. Multiple agonists acting as ligands on various gastrointestinal hormone receptors are a novel pharmacological development. In addition to glucagon-like peptide 1 (GLP-1), these multiple agonists also have glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon receptors as target structures for their pharmacological action. The multiple agonist action is designed to increase glycaemic effects as well as the effects on body weight. This article provides an overview of GLP-1RA and the multiple agonists. Among the dual agonists, the GIP/GLP-1-agonist tirzeptide has been approved for the treatment of type‑2 diabetes, and clinical studies with tirzepatide as a treatment for obesity are ongoing. The currently available data on studies with GLP-1/glucagon agonists and triple agonists are also summarized.
    MeSH term(s) Humans ; Gastrointestinal Hormones/therapeutic use ; Incretins/therapeutic use ; Glucagon-Like Peptide 1/therapeutic use ; Glucagon/therapeutic use ; Diabetes Mellitus, Type 2/drug therapy
    Chemical Substances Gastrointestinal Hormones ; Incretins ; Glucagon-Like Peptide 1 (89750-14-1) ; Glucagon (9007-92-5)
    Language German
    Publishing date 2023-01-04
    Publishing country Germany
    Document type English Abstract ; Journal Article ; Review
    ISSN 2731-7099
    ISSN (online) 2731-7099
    DOI 10.1007/s00108-022-01447-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  7. Article: Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity.

    Gallwitz, Baptist

    Frontiers in endocrinology

    2022  Volume 13, Page(s) 1004044

    Abstract: Incretin-based therapies with glucagon-like peptide-1 receptor agonists (GLP-1RA) are already established in the treatment of type 2 diabetes (T2D). The development of novel dual- or triple-receptor agonists that bind to the receptors not only for GLP-1 ... ...

    Abstract Incretin-based therapies with glucagon-like peptide-1 receptor agonists (GLP-1RA) are already established in the treatment of type 2 diabetes (T2D). The development of novel dual- or triple-receptor agonists that bind to the receptors not only for GLP-1 but also to the receptors for glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon is intended to address different metabolic pathways for carbohydrate, lipid, and protein metabolism simultaneously. Dual- and triple-receptor agonists acting
    MeSH term(s) Humans ; Glucagon-Like Peptide-1 Receptor/agonists ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/metabolism ; Glucagon-Like Peptide 1/metabolism ; Obesity/drug therapy ; Obesity/metabolism
    Chemical Substances tirzepatide (OYN3CCI6QE) ; Glucagon-Like Peptide-1 Receptor ; Glucagon-Like Peptide 1 (89750-14-1)
    Language English
    Publishing date 2022-10-13
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2022.1004044
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  8. Article: Diabetestherapie bei herzkranken Patienten

    Gallwitz, Baptist

    Diabetologie und Stoffwechsel

    2023  Volume 18, Issue 01, Page(s) 44–56

    Keywords Diabetes mellitus ; orale Diabetestherapie ; Hypoglykämierisiko ; kardiovaskuläre Erkrankung ; Niereninsuffizienz ; diabetes mellitus ; oral diabetes therapy ; hypoglycemic risk ; cardiovascular disease ; renal insufficiency
    Language German
    Publishing date 2023-02-01
    Publisher Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 2222993-0
    ISSN 1861-9010 ; 1861-9002
    ISSN (online) 1861-9010
    ISSN 1861-9002
    DOI 10.1055/a-1930-2899
    Database Thieme publisher's database

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 6479: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)
    Zs.A 6479/X: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  9. Article: Diabetestherapie bei herzkranken Patienten

    Gallwitz, Baptist

    Diabetes aktuell

    2023  Volume 21, Issue 03, Page(s) 123–132

    Abstract: Wenn es nicht möglich ist, die glykämischen Behandlungsziele mit nicht-medikamentösen Maßnahmen zu erreichen, soll innerhalb weniger Monate – oder bei Stoffwechseldekompensation sofort – mit einer medikamentösen Diabetestherapie begonnen werden. Dabei ... ...

    Abstract Wenn es nicht möglich ist, die glykämischen Behandlungsziele mit nicht-medikamentösen Maßnahmen zu erreichen, soll innerhalb weniger Monate – oder bei Stoffwechseldekompensation sofort – mit einer medikamentösen Diabetestherapie begonnen werden. Dabei müssen individualisierte Therapieziele unter Einbezug des individuellen kardiovaskulären und renalen Risikos definiert werden.
    Language German
    Publishing date 2023-05-01
    Publisher Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 2225026-8
    ISSN 1864-1733 ; 1861-6089 ; 1617-0482
    ISSN (online) 1864-1733
    ISSN 1861-6089 ; 1617-0482
    DOI 10.1055/a-2069-1968
    Database Thieme publisher's database

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 6239: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)
    6239/X: Show issues

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  10. Article: Multiple Agonisten - die Zukunft in der Diabetestherapie?

    Gallwitz, Baptist

    Kompendium Diabetes

    2022  Volume -, Issue Mai, Page(s) 46

    Language German
    Document type Article
    ZDB-ID 2234717-3
    ISSN 1861-8413
    Database Current Contents Medicine

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 6304: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top